Clinical Trial Update: Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining nivolumab and brentuximab vedotin in untreated Hodgkin lymphoma in older patients; the study is active-not-recruiting and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma
• Hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)
• OPDIVO (nivolumab)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-09-22